News | News By Subject | News by Disease News By Date | Search News

Liver or Gallbladder Disorder (misc) News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Why Intercept Pharma (ICPT) Stock Jumped Nearly 10% On Friday After Providing Phase III Update     2/13/2017
Here's a Look at Allergan (AGN)'s Opportunity in NASH     1/16/2017
Bristol-Myers Squibb (BMY) Slams Down $100 Million to Make a Play Into NASH     11/14/2016
Gilead (GILD) Looking Even Weaker on the R&D Front as It Racks Up Some More Clinical Failures in Q3 Report     11/2/2016
The $40 Billion NASH Market and the 3 Biotechs That Stand to Profit From it     11/2/2016
Massachusetts's Alnylam (ALNY) Falls After Stopping Development of RNAi Liver Disease Candidate ALN-AAT     10/3/2016
Galectin (GALT) Stock Craters After Phase IIa NASH Failure     9/28/2016
This Biotech Has the Upper Hand Over Allergan (AGN) and Gilead (GILD) in the Heated Nash Battle     9/23/2016
Allergan (AGN)'s NASH Spree Continues With $50 Million+ Buyout of San Diego's Akarna Therapeutics     9/21/2016
Gilead (GILD) to Release Data on 9 Clinical Trials Before End of the Year     9/16/2016
Tobira (TBRA) Stock Loses More Than Half Its Value After Phase IIb Trial Miss     7/25/2016
Intercept Pharma (ICPT)'s Liver Drug Wins Accelerated Approval by the FDA     5/31/2016
Struggling Ariad (ARIA)'s Luck Might be Turning Around as Company Eyes Pfizer (PFE)'s ALK Space     4/13/2016
FDA Panel Unanimously Backs Speedy Approval of Intercept Pharma (ICPT)'s Liver Disease Drug Ocaliva     4/11/2016
Jazz Pharma (JAZZ) Finally Bags FDA Approval for Rare Liver Disorder Drug Defitelio     3/31/2016

News from Around the Web
Liver Disease In Children Linked To Fructose Intake, Journal of Hepatology Reveals     2/15/2017
Allergan (AGN) R&D Chief Reveals 6 Drugs That Could be Potential Blockbusters     2/14/2017
4 Small Biotechs That Could Give Gilead (GILD), Merck & Co. (MRK) Pfizer (PFE) Some Competition With NASH     10/7/2016
Citrus Fruits Could Help Prevent Obesity, Universidade Estadual Paulista Study     8/22/2016
Simple Blood Test Developed To Screen For Life-Threatening Liver Disease, Baylor College of Medicine Study     8/11/2016
A Colony Of Fat Mice Hidden In A Norfolk Lab Could Hold The Key For Liver Disease, Eastern Virginia Medical School Study     7/26/2016
Salem Nonprofit, Design That Matters, Creates Device To Treat Jaundice In Developing World     7/21/2016
Even Light Drinkers Should Watch For Fatty Liver Disease, Kumamoto University Study     5/25/2016
How Fasting Helps Fight Fatty Liver Disease, Helmholtz Zentrum Munchen Study     5/10/2016
How Waist Size Can Predict Liver Disease Risk, University Of Milan Study     4/18/2016
Why It Feels So Good To Scratch An Itch, Published In Proceedings Of The Entomological Society Of Washington     2/29/2016
Biotech Startup Pandorum Technologies Creates India’s First 3D Printed Artificial Human Liver Tissue     12/29/2015
Could Image Mapping Offer Way To Do Noninvasive Liver Biopsies?     10/20/2015
New Device Promises Expedited Results For Detecting Liver Toxicity, Nanyang Technological University Study     9/24/2015
"Our Chairs Are Killing Us," Say Sungkyunkwan University School Of Medicine Researchers     9/16/2015

Press Releases
Intercept Pharma (ICPT) Release: NICE Recommends Ocaliva® (Obeticholic Acid) For The Treatment Of Patients With Primary Biliary Cholangitis In England, Wales And Northern Ireland     3/2/2017
New Preclinical Data Show Can-Fite BioPharma (CFBI)'s Namodenoson (CF102) Prevents Progression Of Liver Fibrosis     2/28/2017
NeuroVive (NVP) Appoints Recognized Scientific Advisors And Enters Research Agreements In NASH And Hepatocellular Carcinoma     2/22/2017
CoCrystal To Present Clinical Data On Its Potent Pan-Genotypic NS5B Non-Nucleoside Inhibitor CC-31244 At The Asian Pacific Association For The Study Of The Liver (APASL) Annual Meeting     2/17/2017
Trek Therapeutics Announces Oral Presentation Of Faldaprevir, TD-6450 And Ribavirin Ph2a Trial Results At The Asian Pacific Association For The Study Of The Liver On February 18, 2017 In Shanghai     2/13/2017
Bay Area's Ocera Therapeutics (OCRX) Plunges as Lead Drug Flunks Mid-Stage Hepatic Encephalopathy Study     1/30/2017
DURECT (DRRX) Announces Update On DUR-928 Development Program     1/30/2017
Galmed Pharmaceuticals Completes Patient Recruitment For ARREST Phase IIb NASH Study     1/9/2017
Can-Fite BioPharma (CFBI) Receives IRB Approval To Commence Patient Enrollment In Phase II NAFLD/NASH Trial In Q1 2017     1/9/2017
HepaRegeniX GmbH Raises €9 Million In A Series A Financing To Develop Kinase Inhibitors For The Treatment Of Acute And Chronic Liver Diseases     1/5/2017
FDA Grants Fast Track Designation To Enanta Pharmaceuticals, Inc.’s FXR Agonist Candidate, EDP-305, For The Treatment Of NASH With Liver Fibrosis     1/4/2017
New Preclinical Data Show Can-Fite BioPharma (CFBI)'s Namodenoson (CF102) Inhibits Liver Fibrosis -- Supports Potential Efficacy In Treatment Of NASH     12/16/2016
European Commission (EC) Grants Intercept Pharma (ICPT)’s Ocaliva (Obeticholic Acid) Marketing Authorization For The Treatment Of Primary Biliary Cholangiti     12/14/2016
Arcturus Therapeutics Announces Collaboration With Takeda (TKPYY) To Develop RNA-Based Therapeutics For The Treatment Of Nonalcoholic Steatohepatitis (NASH)     12/7/2016
Gilead (GILD) Release: Phase 2 Data For Selonsertib In Nonalcoholic Steatohepatitis (NASH) Presented At The Liver Meeting 2016     11/15/2016

//-->